Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina

Lancet

Volumn 350, Issue 9082, 1997, Pages 922-927

  Mostad, Sara B ^a   Overbaugh, Julie ^a   DeVange, Dana M ^a   Welch, Mary J ^a   Chohan, Bhavna ^b   Mandaliya, Kishorchandra ^b   Nyange, Patrick ^c   Martin Jr , Harold L ^a   Ndinya Achola, Jeckoniah ^c   Bwayo, Job J ^c   Kreiss, Joan K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Department of Obstetrics and Gynaecology   (Kenya)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; RETINOL;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINOL DEFICIENCY; RISK FACTOR; SEXUAL TRANSMISSION; TRICHOMONAS VAGINALIS; UTERINE CERVIX; VAGINA CANDIDIASIS; VAGINA SECRETION; VERTICAL TRANSMISSION; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 0031588179     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04240-2     Document Type: Article

References (37)

1. 1 Quinn TC. Global burden of the HIV pandemic. Lancet 1996; 348: 99-106.
2. 2 Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994; 5: 252-65.
3. 3 Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; i: 527-29.
4. 4 Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Couland JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immun Defic Syndr 1993; 6: 72-75.
5. 5 Clemetson DBA, Moss GB, Willerford D, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993; 269: 2860-64.
6. 6 Kreiss J, Willerford D, Hensel M, et al. Association between cervical inflammation and cervical shedding of HIV DNA. J Infect Dis 1994; 170: 1597-601.
7. 7 John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression and abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175: 57-62.
8. 8 Van de Perre P, De Clerq A, Cogniaux-Leclerq J, Nzaramba D, Butzler JP, Sprecher-Goldberg S. Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med 1988; 64: 30-33.
9. 9 Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
10. 10 Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27: 251-56.
11. 11 Landay A, Ho JL, Hom D, et al. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 1993; 7: 1565-68.
12. 12 Sommer A, West KP. Vitamin A deficiency: health, survival, and vision. New York: Oxford University Press, 1996.
13. 13 Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994; 19: 489-99.
14. 14 Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 depletion. J Infect Dis 1995; 172: 1469-75.
15. 15 Schlesselman JJ. Case-control studies. New York: Oxford University Press; 1982: 200-06.
16. 16 Amatayakul K. Metabolism: vitamins and trace elements. In: Goldzieher J, ed. Pharmacology of the contraceptive steroids. New York: Raven Press, 1994: 363-77.
17. 17 Ghosh D. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat. J Virol 1992; 66: 586-90.
18. 18 Furth PA, Westphal H, Hennighausen L. Expression from the HIV-LTR is stimulated by glucocorticoids and pregnancy. AIDS Res Hum Retrovir 1990; 6: 553-60.
19. 19 Kolesnitchenko V, Snart RS. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation. AIDS Res Hum Retrovir 1992; 8: 1977-80.
20. 20 Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 1984; 5: 435-55.
21. 21 Schuurs AHWM, Geurts TBP, Goorissen EM, Hazes JMW, Verheul HAM. Immunologic effects of estrogens, progestins, and estrogen-progestin combinations. In: Goldzieher J, ed. Pharmacology of the contraceptive steroids. New York: Raven Press, 1994: 379-99.
22. 22 Mishell DR, Thorneycroft IH, Nakamura RM, Nagata Y, Stone SC. Serum estradiol in women ingesting combination oral contraceptive steroids. Am J Obstet Gynecol 1972; 114: 923-28.
23. 23 Oritz A, Horio M, Stanczyk FZ, Goebelsmann U, Mishell DR. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 1977; 44: 32-38.
24. 24 Speroff L, Darney P. A clinical guide for contraception, 2nd edn. Baltimore: Williams and Wilkins, 1996: 25-117.
25. 25 Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing d1-norgestrel. Am J Obsetet Gynecol 1977; 129: 133-40.
26. 26 Carol W, Klinger B, Jager R, Kasch R, Brandstadt A. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations. Exp Clin Endocrinol 1992; 99: 12-17.
27. 27 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-26.
28. 28 European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV-1 in 563 staple couples. BMJ 1992; 304: 809-13.
29. 29 Yamaguchi K, Groopman JE, Byrn RA. The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS 1994; 8: 1675-82.
30. 30 Towers G, Harris J, Lang G, Collins MKL, Latchman DS. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter. AIDS 1995; 9: 129-36.
31. 30 Towers G, Harris J, Lang G, Collins MKL, Latchman DS. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter. AIDS 1995; 9: 129-36.
32. 31 Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-97.
33. 32 Cormack D. Ham's histology, 9th edn. Philadelphia: J B Lippincott, 1987: 638-44.
34. 33 Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type I. J Infect Dis 1991; 163: 233-39.
35. 34 Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344: 246-48.
36. 35 Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-36.
37. 36 Eron JJ, Gilliam B, Fiscus S, Dyer J, Cohen MS. HIV-1 shedding and chlamydia urethritis. JAMA 1996; 275: 36.